Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 1.623.86-41.80-15.630.67

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 1.62 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar20251.62
Mar20243.86
Mar2023-41.80
Mar2022-15.63
Mar20210.67

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 1.62
-58.03
Mar2024 3.86
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63
Negative
Mar2021 0.67 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹199.2 Cr -2.7% -9% -56.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,842.0 Cr 1.1% 4.6% 14.2% Stock Analytics
DIVIS LABORATORIES ₹193,860.0 Cr 0.6% 8.3% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹192,687.0 Cr 6.3% 12.2% 45.5% Stock Analytics
CIPLA ₹112,593.0 Cr -1.7% -2.8% -4% Stock Analytics
DR REDDYS LABORATORIES ₹97,364.9 Cr -3.7% -10.4% -6% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-2.7%

-9%

-56.7%

SENSEX

-1%

-0.9%

-7.5%


You may also like the below Video Courses